NASDAQ:BZ

Kanzhun Limited (BOSS Zhipin) Financial Overview

Font: Financial Modeling Prep  • Mar 18, 2026

Market Chart
  • Earnings per Share (EPS) of $0.27, slightly below estimates.
  • Revenue reported at approximately $297.1 million, missing estimates.
  • Financial Health indicated by a low debt-to-equity ratio and a strong current ratio.

Kanzhun Limited, known as "BOSS Zhipin," operates as a leading online recruitment platform in China. It is listed on the NASDAQ under the symbol BZ and also trades on the Hong Kong Stock Exchange with the code 2076. The company provides a platform for job seekers and employers to connect, making it a significant player in the recruitment industry.

On March 18, 2026, BZ reported earnings per share (EPS) of $0.27, slightly below the estimated $0.278. This minor miss in EPS can be crucial for investors as it reflects the company's profitability per share. Despite this, BZ maintains a price-to-earnings (P/E) ratio of approximately 17.4, indicating investor confidence in its future earnings potential.

The company's revenue for the period was approximately $297.1 million, falling short of the estimated $299.4 million. This shortfall in revenue might concern some investors, but BZ's price-to-sales ratio of about 5.41 suggests that the market still values the company highly relative to its revenue. The enterprise value to sales ratio of 4.84 further supports this valuation.

BZ's financial health is underscored by its low debt-to-equity ratio of about 0.009, indicating minimal reliance on debt. This is complemented by a strong current ratio of approximately 4.18, showcasing the company's ability to cover short-term liabilities. These metrics highlight BZ's solid financial foundation and liquidity position.

The company's earnings yield stands at approximately 5.75%, offering investors a perspective on the return on investment. Additionally, the enterprise value to operating cash flow ratio of around 9.27 provides insight into BZ's cash flow efficiency, an important factor for assessing the company's operational performance.

Market Overview
LIMN
Liminatus Pharma, Inc. Class A Common Stock
$0.28
48.56%
SBFM
Sunshine Biopharma, Inc.
$0.51
38.06%
SOXS
Direxion Daily Semiconductor Bear 3X ETF
$8.54
0.00%
TZA
Direxion Daily Small Cap Bear 3X ETF
$4.82
-0.21%
NVDA
NVIDIA Corporation
$220.19
-1.47%
WOK
WORK Medical Technology Group Ltd.
$0.15
-22.65%
CXAI
CXApp Inc.
$0.22
21.97%
RGTI
Rigetti Computing, Inc.
$21.16
25.33%
NIVF
NewGenIvf Group Limited
$1.14
54.26%
NCPL
Netcapital Inc.
$0.68
48.84%